Cargando…
REGγ ablation impedes dedifferentiation of anaplastic thyroid carcinoma and accentuates radio-therapeutic response by regulating the Smad7-TGF-β pathway
Anaplastic thyroid cancer (ATC) is the most aggressive human thyroid malignancy, characterized by dedifferentiation and resistance to radioiodine therapy. The underlying mechanisms regulating ATC dedifferentiation are largely unknown. Here, we show that REGγ, a noncanonical proteasome activator high...
Autores principales: | Jiao, Chan, Li, Lin, Zhang, Pei, Zhang, Li, Li, Ke, Fang, Riqun, Yuan, Lei, Shi, Kaixuan, Pan, Linan, Guo, Qiannan, Gao, Xiao, Chen, Geng, Xu, Shichen, Wang, Qingwei, Zuo, Di, Wu, Wei, Qiao, Shanlou, Wang, Xiaoshuang, Moses, Robb, Xiao, Jianru, Li, Lei, Dang, Yongyan, Li, Xiaotao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205985/ https://www.ncbi.nlm.nih.gov/pubmed/31243343 http://dx.doi.org/10.1038/s41418-019-0367-9 |
Ejemplares similares
-
The REGγ-proteasome forms a regulatory circuit with IκBɛ and NFκB in experimental colitis
por: Xu, Jinjin, et al.
Publicado: (2016) -
Aging-associated REGγ proteasome decline predisposes to tauopathy
por: Tu, Jialu, et al.
Publicado: (2022) -
The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020) -
Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells
por: Ali, Amjad, et al.
Publicado: (2013) -
Author Correction: The REGγ inhibitor NIP30 increases sensitivity to chemotherapy in p53-deficient tumor cells
por: Gao, Xiao, et al.
Publicado: (2020)